Detalhe da pesquisa
1.
Neutralizing immunity in vaccine breakthrough infections from the SARS-CoV-2 Omicron and Delta variants.
Cell
; 185(9): 1539-1548.e5, 2022 04 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35429436
2.
Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant.
Cell
; 184(13): 3426-3437.e8, 2021 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33991487
3.
Neutralizing Immunity Induced Against the Omicron BA.1 and BA.2 Variants in Vaccine Breakthrough Infections.
J Infect Dis
; 226(10): 1688-1698, 2022 11 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36134603
4.
Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California.
Nat Microbiol
; 7(2): 277-288, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35013591
5.
A diagnostic host response biosignature for COVID-19 from RNA profiling of nasal swabs and blood.
Sci Adv
; 7(6)2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33536218
6.
Transmission, infectivity, and antibody neutralization of an emerging SARS-CoV-2 variant in California carrying a L452R spike protein mutation.
medRxiv
; 2021 Mar 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33758899